PL03.09: Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2)
暂无分享,去创建一个
R. Ramlau | S. Ramalingam | D. Fennell | T. Ciuleanu | R. Pillai | M. Schenker | B. Perin | D. Kowalski | V. Vukovic | I. Yalcin | F. Teofilovici | V. Kovcin | V. Vukovic